{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:42:48Z","timestamp":1760146968968},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.braindev.2011.04.005","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T01:38:11Z","timestamp":1304213891000},"page":"251-254","source":"Crossref","is-referenced-by-count":8,"title":["Another promising treatment option for neuroblastoma-associated opsoclonus\u2013myoclonus syndrome by oral high-dose dexamethasone pulse: Lymphocyte markers as disease activity"],"prefix":"10.1016","volume":"34","author":[{"given":"Makiko","family":"Oguma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Kashii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko Y.","family":"Momoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2011.04.005_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.canlet.2005.01.051","article-title":"Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004","volume":"228","author":"Matthay","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.braindev.2011.04.005_b0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mpo.1138","article-title":"Opsoclonus\u2013myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children\u2019s Cancer Group Study","volume":"36","author":"Rudnick","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.braindev.2011.04.005_b0015","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00043426-200411000-00006","article-title":"Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus\u2013myoclonus","volume":"26","author":"Pranzatelli","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.braindev.2011.04.005_b0020","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.20125","article-title":"CSF B-cell expansion in opsoclonus\u2013myoclonus syndrome: a biomarker of disease activity","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.braindev.2011.04.005_b0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0029-1237723","article-title":"Long-term follow-up of neuroblastoma-associated opsoclonus\u2013myoclonus-ataxia syndrome","volume":"40","author":"De Grandis","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2011.04.005_b0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","article-title":"Rituximab (anti-CD20) adjunctive therapy for opsoclonus\u2013myoclonus syndrome","volume":"28","author":"Pranzatelli","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.braindev.2011.04.005_b0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2006-955931","article-title":"High dose pulsatile dexamethasone therapy in children with opsoclonus\u2013myoclonus syndrome","volume":"37","author":"Rost\u00e1sy","year":"2006","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2011.04.005_b0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/pbc.21107","article-title":"Treatment of neuroblastoma-related opsoclonus\u2013myoclonus-ataxia syndrome with high-dose dexamethasone pulses","volume":"50","author":"Ertle","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.braindev.2011.04.005_b0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1651-2227.1992.tb12248.x","article-title":"High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome","volume":"81","author":"Sugie","year":"1992","journal-title":"Acta Paediatr"},{"year":"1995","key":"10.1016\/j.braindev.2011.04.005_b0050"},{"key":"10.1016\/j.braindev.2011.04.005_b0055","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus\u2013myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2011.04.005_b0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2249.2009.03987.x","article-title":"Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis","volume":"158","author":"Xu","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.braindev.2011.04.005_b0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T22:30:15Z","timestamp":1543789815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760411000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0387760411000945"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2011.04.005","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}